This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain.
15 July 2025
Concurrent Technologies Plc
(the "Company" or the "Group")
Trading Update
Concurrent Technologies Plc (AIM: CNC), a designer and manufacturer of leading-edge computer products, systems and mission critical solutions used in high-performance markets by some of the world's major OEMs, provides an update on trading for the six months to 30 June 2025 ("H1 FY25").
Based on its unaudited management accounts for H1 FY25, the Company expects to report record results for a first half, with revenue of approximately £21.3m (H1 FY24: £16.8m) and profit before tax of approximately £2.4m (H1 FY24: £2.3m) despite the USD exchange rate having a c.£0.6m negative impact to profit relative to the same period last year . Order intake for the period remained strong at £22.3m (H1 FY24 £17.8m).
The Company continues to secure design wins, across both the Products and Systems business units, in line with the transformative performance of 2023 and 2024, further underpinning confidence in medium- and long-term growth, whereby a design win typically yields purchase orders two to three years later, often with a lifetime for seven-10 years thereafter.
The Board believes that the Company is well positioned to deliver full year results for 2025 in line with current market expectations*.
Miles Adcock, CEO of Concurrent Technologies, commented: "The Group has delivered a solid first half with record results for H1 FY25 revenue, profit, and order intake. The Products business unit continues to perform well, securing new strategic wins, and the Systems business is mobilising, reinforcing our confidence in good revenue generation for the full year. The latter is on track to nearing a break-even position, following planned up-front investment to support long-term growth in 2024.
"We are committed to bringing the latest technology to market as early as possible and are encouraged by the early success of our Kratos product, launched in the half, which remains unique in the market. It is currently the only computer board of its form factor to feature the industrial variant of the Intel® Xeon® 6 processor and is generating significant interest across our customer base.
"H2 FY25 has started well and while we remain mindful that, like all defence businesses, we do have some dependency on contracts from the US, where there is potential for headwinds associated with governmental reviews or global supply chain disruption, we are closely monitoring developments and remain on track to meet full-year expectations."
* In so far as the Board is aware, consensus market expectations for FY25 are revenues of £43m and profit before tax of £6m.
Enquiries:
| Concurrent Technologies Plc Kim Garrod - CFO
|
+44 (0)1206 752626 |
| Alma Strategic Communications Josh Royston Will Merison
|
|
| Cavendish Capital Markets Limited (NOMAD & Broker) Peter Lynch |
+44 (0)131 220 9772 |
About Concurrent Technologies Plc
Concurrent Technologies Plc develops and manufactures high-end embedded plug-in cards and systems for use in a wide range of high-performance, long-life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products feature Intel® processors, including the latest generation embedded Intel® Core™ processors, Intel® Xeon® and Intel Atom™ processors. The products are designed to be compliant with industry specifications and support many of today's leading embedded operating systems. The products are sold world-wide.
For more information on Concurrent Technologies Plc and its products please visit www.concurrent.tech .
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.